Molecular Modeling of Human CCR2 Receptor within POPC Lipid Bilayer

被引:0
|
作者
Ahmad Ebadi
Dara Dastan
Mojtaba Azami
Adibe Karimi
Nima Razzaghi-Asl
机构
[1] Hamadan University of Medical Sciences,Department of Medicinal Chemistry, School of Pharmacy
[2] Hamadan University of Medical Sciences,Medicinal Plants and Natural Products Research Center
[3] Hamadan University of Medical Sciences,Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy
[4] Ardabil University of Medical Sciences,Department of Medicinal Chemistry, School of Pharmacy
来源
Structural Chemistry | 2017年 / 28卷
关键词
Homology modeling; Docking; MD simulation; CCR2; Inflammation; INCB3344;
D O I
暂无
中图分类号
学科分类号
摘要
Chemokine receptor 2 (CCR2), a G-protein coupled receptor (GPCR), is a critical target for several inflammatory and autoimmune diseases. The main restriction on designing desirable antagonists against CCR2 is the lack of appropriate crystal structure for this target. In the absence of such experimental data, computational methods triggering structure prediction provide a cost-effective option. Homology modeling has been widely used to explore GPCR structure. Within the present contribution, homology modeling, molecular docking and molecular dynamics (MD) simulation were applied to construct a reliable model for CCR2. In the present contribution, we docked INCB3344, one of the most potent CCR2 inhibitors, into the active site of the CCR2 protein. Subsequently, we studied the dynamic behavior of INCB3344-CCR2 complex in the presence of lipid membrane. Moreover; a detailed molecular mechanism of INCB3344 action has been proposed. It was revealed that Tyr120, His121, Tyr259 and Glu291 formed H-bond interactions with INCB3344 while residues such as Trp98, His202, Thr203 and Thr173 participated in hydrophobic interactions. As a consequence, a reliable homology model of CCR2 could be successfully developed on the basis of CCR5 crystallographic structure. Finally it was found that binding of INCB3344 led to the structural changes in CCR2 that provided more interaction sites. Results of this study may be useful to design further CCR2 inhibiting structures with the aim of developing desirable therapeutic agents.
引用
收藏
页码:849 / 857
页数:8
相关论文
共 50 条
  • [41] Discovery and profile of cyclopentylamines as inhibitors of chemokine receptor CCR2
    Winters, Michael P.
    O'Neill, John
    Hou, Cuifen
    Johnson, Dana
    Sui, Zhihua
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [42] The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis
    Marlon P. Quinones
    Carlos A. Estrada
    Yogeshwar Kalkonde
    Sunil K. Ahuja
    William A. Kuziel
    Matthias Mack
    Seema S. Ahuja
    Journal of Molecular Medicine, 2005, 83 : 672 - 681
  • [43] The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis
    Quinones, MP
    Estrada, CA
    Kalkonde, Y
    Ahuja, SS
    Kuziel, WA
    Mack, M
    Ahuja, SS
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (09): : 672 - 681
  • [44] Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5
    Dawson, John R. D.
    Kufareva, Irina
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 185A - 185A
  • [45] The CCR2 Antagonist CCX140 Improves Renal Function and Hyperglycemia in Diabetic Mice Expressing Human CCR2
    Powers, Jay P.
    Sullivan, Timothy J.
    Miao, Zhenhua
    Zhao, Niky
    Berahovich, Robert D.
    Ertl, Linda
    Walters, Matthew J.
    Dang, Ton
    Miao, Shichang
    Jaen, Juan C.
    Schall, Thomas J.
    DIABETES, 2013, 62 : A27 - A27
  • [46] Inducing Receptor Degradation as a Novel Approach to Target CC Chemokine Receptor 2 (CCR2)
    Zacarias, Natalia V. Ortiz
    Roth, Sascha
    Broekhuis, Jeremy D.
    van der Es, Daan
    Moreau, Kevin
    Heitman, Laura H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [47] Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis
    Zhao, XY
    Gharizadeh, B
    Hjelmström, P
    Pirskanen, R
    Nyrén, P
    Lefvert, AK
    Ghaderi, M
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (05) : 749 - 753
  • [48] CCR2 AND CCR5 CHEMOKINE RECEPTOR POLYMORPHISMS AND THEIR INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Schauren, Juliana
    Consiglio, Camila R.
    Monticielo, Odirlei A.
    Xavier, Ricardo M.
    Brenol, Joao C.
    Chies, Jose A.
    TISSUE ANTIGENS, 2013, 81 (05): : 320 - 320
  • [49] THE CCR2 ANTAGONIST CCX140 IMPROVES RENAL FUNCTION IN TWO TYPES OF DIABETIC MICE EXPRESSING HUMAN CCR2
    Powers, Jay
    Sullivan, Timothy
    Miao, Zhenhua
    Berahovich, Rob
    Ertl, Linda
    Walters, Matthew
    Miao, Shichang
    Jaen, Juan
    Schall, Thomas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 51 - 51
  • [50] Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3
    Zhehua Shao
    Yangxia Tan
    Qingya Shen
    Li Hou
    Bingpeng Yao
    Jiao Qin
    Peiyu Xu
    Chunyou Mao
    Li-Nan Chen
    Huibing Zhang
    Dan-Dan Shen
    Chao Zhang
    Weijie Li
    Xufei Du
    Fei Li
    Zhi-Hua Chen
    Yi Jiang
    H. Eric Xu
    Songmin Ying
    Honglei Ma
    Yan Zhang
    Huahao Shen
    Cell Discovery, 8